
MSCI · NYSE
The supplied house consensus is Buy across 16 analysts, with a mean target of $700; low and high values are not provided in that consensus. Recent named targets cluster around $690-$727, including Rothschild & Co Redburn at $690, Morgan Stanley at $700, UBS at $720, and Morgan Stanley's separately reported $727 high, but other aggregators show $639.3 and $643 targets, making the spread materially wider. Morgan Stanley is the most bullish named recent analyst on the available high-target data, while Exane BNP Paribas is the least bullish at a stale $450 from 2023. Revisions were mixed over the past week of evidence: Morgan Stanley cut its target on estimate reductions, while Clear Street and UBS raised theirs.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Rothschild & Co Redburn | — | $690 | +24.6% | Jun 18, 2026 | Open the report this row came from | |
| Weiss Ratings | — | — | — | Jun 15, 2026 | Open the report this row came from |